L Saba1, G Lanzino2, P Lucatelli3, F Lavra4, R Sanfilippo4, R Montisci4, J S Suri5,6, C Yuan7,8. 1. From the Department of Radiology (L.S., F.L., R.S., R.M.), Azienda Ospedaliero Universitaria di Cagliari, Monserrato (Cagliari), Italy lucasaba@tiscali.it. 2. Department of Neurologic Surgery (G.L.), Mayo Clinic, Rochester, Minnesota. 3. Department of Radiological, Oncological and Anatomopathological Sciences-Radiology (P.L.), Sapienza University of Rome, Rome, Italy. 4. From the Department of Radiology (L.S., F.L., R.S., R.M.), Azienda Ospedaliero Universitaria di Cagliari, Monserrato (Cagliari), Italy. 5. Diagnostic and Monitoring Division (J.S.S.), Atheropoint, Roseville, California. 6. Department of Electrical Engineering (J.S.S.), University of Idaho, Moscow, Idaho. 7. Center for Biomedical Imaging Research (C.Y.), Department of Biomedical Engineering, Tsinghua University School of Medicine, Beijing, China. 8. Department of Radiology (C.Y.), University of Washington, Seattle, Washington.
Abstract
BACKGROUND AND PURPOSE: The presence of IPH is considered the most dangerous feature because it is significantly associated with clinical ipsilateral cerebrovascular events. Our aim was to explore the characterization of plaque with CT in symptomatic subjects with bilateral intraplaque hemorrhage. MATERIALS AND METHODS: Three-hundred-forty-three consecutive patients with recent anterior circulation ischemic events (<2 weeks) and CT of the carotid arteries (performed within 14 days of the cerebrovascular event) evaluated between June 2012 and September 2017 were analyzed for plaque volume composition to identify all subjects with bilateral intraplaque hemorrhage. Plaque volume was semiautomatically measured, and tissue components were classified according to the attenuation values such as the following: calcified (for values of ≥130 HU), mixed (for values of ≥60 and <130 HU), lipid (for values of ≥25 and <60 HU), and intraplaque hemorrhage (for values of <25 HU). Twenty-one subjects (15 men; mean age, 70 ± 11 years; range, 44-87 years) had bilateral intraplaque hemorrhage and were included in the analysis. RESULTS: Volume measurement revealed significantly larger plaques on the symptomatic side compared with the asymptomatic one (mean, 28 ± 9 versus 22 ± 8 mm, P = .007). Intraplaque hemorrhage volume and percentage were also significantly higher in the plaque ipsilateral to the cerebrovascular event (P < .001 and < .001, respectively). The volume of other plaque components did not show a statically significant association except for lipid and lipid + intraplaque hemorrhage percentages (23% versus 18% and 11% versus 15%), which were significantly different between the symptomatic and the asymptomatic sides (.016 and .011, respectively). The intraplaque hemorrhage/lipid ratio was higher on the symptomatic side (0.596 versus 0.171, P = .001). CONCLUSIONS: In patients with bilateral intraplaque hemorrhage and recent ischemic symptoms, the plaque ipsilateral to the symptomatic side has significantly larger volume and a higher percentage of intraplaque hemorrhage compared with the contralateral, asymptomatic side.
BACKGROUND AND PURPOSE: The presence of IPH is considered the most dangerous feature because it is significantly associated with clinical ipsilateral cerebrovascular events. Our aim was to explore the characterization of plaque with CT in symptomatic subjects with bilateral intraplaque hemorrhage. MATERIALS AND METHODS: Three-hundred-forty-three consecutive patients with recent anterior circulation ischemic events (<2 weeks) and CT of the carotid arteries (performed within 14 days of the cerebrovascular event) evaluated between June 2012 and September 2017 were analyzed for plaque volume composition to identify all subjects with bilateral intraplaque hemorrhage. Plaque volume was semiautomatically measured, and tissue components were classified according to the attenuation values such as the following: calcified (for values of ≥130 HU), mixed (for values of ≥60 and <130 HU), lipid (for values of ≥25 and <60 HU), and intraplaque hemorrhage (for values of <25 HU). Twenty-one subjects (15 men; mean age, 70 ± 11 years; range, 44-87 years) had bilateral intraplaque hemorrhage and were included in the analysis. RESULTS: Volume measurement revealed significantly larger plaques on the symptomatic side compared with the asymptomatic one (mean, 28 ± 9 versus 22 ± 8 mm, P = .007). Intraplaque hemorrhage volume and percentage were also significantly higher in the plaque ipsilateral to the cerebrovascular event (P < .001 and < .001, respectively). The volume of other plaque components did not show a statically significant association except for lipid and lipid + intraplaque hemorrhage percentages (23% versus 18% and 11% versus 15%), which were significantly different between the symptomatic and the asymptomatic sides (.016 and .011, respectively). The intraplaque hemorrhage/lipid ratio was higher on the symptomatic side (0.596 versus 0.171, P = .001). CONCLUSIONS: In patients with bilateral intraplaque hemorrhage and recent ischemic symptoms, the plaque ipsilateral to the symptomatic side has significantly larger volume and a higher percentage of intraplaque hemorrhage compared with the contralateral, asymptomatic side.
Authors: L Saba; C Yuan; T S Hatsukami; N Balu; Y Qiao; J K DeMarco; T Saam; A R Moody; D Li; C C Matouk; M H Johnson; H R Jäger; M Mossa-Basha; M E Kooi; Z Fan; D Saloner; M Wintermark; D J Mikulis; B A Wasserman Journal: AJNR Am J Neuroradiol Date: 2018-01-11 Impact factor: 3.825
Authors: P-J Touboul; M G Hennerici; S Meairs; H Adams; P Amarenco; N Bornstein; L Csiba; M Desvarieux; S Ebrahim; R Hernandez Hernandez; M Jaff; S Kownator; T Naqvi; P Prati; T Rundek; M Sitzer; U Schminke; J-C Tardif; A Taylor; E Vicaut; K S Woo Journal: Cerebrovasc Dis Date: 2012-11-01 Impact factor: 2.762
Authors: Hunter R Underhill; Thomas S Hatsukami; Zahi A Fayad; Valentin Fuster; Chun Yuan Journal: Nat Rev Cardiol Date: 2010-01-26 Impact factor: 32.419
Authors: John C Benson; Heidi Cheek; Marie C Aubry; Giuseppe Lanzino; John Huston Iii; Alejandro Rabinstein; Waleed Brinjikji Journal: Clin Neuroradiol Date: 2021-01-04 Impact factor: 3.649
Authors: L Saba; H Chen; R Cau; G D Rubeis; G Zhu; F Pisu; B Jang; G Lanzino; J S Suri; Y Qi; M Wintermark Journal: AJNR Am J Neuroradiol Date: 2022-02 Impact factor: 3.825
Authors: John C Benson; Valentina Nardi; Melanie C Bois; Luca Saba; Waleed Brinjikji; Luis Savastano; Giuseppe Lanzino; Amir Lerman Journal: Interv Neuroradiol Date: 2021-08-16 Impact factor: 1.764
Authors: L Saba; C Loewe; T Weikert; M C Williams; N Galea; R P J Budde; R Vliegenthart; B K Velthuis; M Francone; J Bremerich; L Natale; K Nikolaou; J N Dacher; C Peebles; F Caobelli; A Redheuil; M Dewey; K F Kreitner; R Salgado Journal: Eur Radiol Date: 2022-10-04 Impact factor: 7.034
Authors: L Saba; S Zucca; A Gupta; G Micheletti; J S Suri; A Balestrieri; M Porcu; P Crivelli; G Lanzino; Y Qi; V Nardi; G Faa; R Montisci Journal: AJNR Am J Neuroradiol Date: 2020-07-30 Impact factor: 3.825
Authors: Narendra N Khanna; Mahesh Maindarkar; Anudeep Puvvula; Sudip Paul; Mrinalini Bhagawati; Puneet Ahluwalia; Zoltan Ruzsa; Aditya Sharma; Smiksha Munjral; Raghu Kolluri; Padukone R Krishnan; Inder M Singh; John R Laird; Mostafa Fatemi; Azra Alizad; Surinder K Dhanjil; Luca Saba; Antonella Balestrieri; Gavino Faa; Kosmas I Paraskevas; Durga Prasanna Misra; Vikas Agarwal; Aman Sharma; Jagjit Teji; Mustafa Al-Maini; Andrew Nicolaides; Vijay Rathore; Subbaram Naidu; Kiera Liblik; Amer M Johri; Monika Turk; David W Sobel; Gyan Pareek; Martin Miner; Klaudija Viskovic; George Tsoulfas; Athanasios D Protogerou; Sophie Mavrogeni; George D Kitas; Mostafa M Fouda; Manudeep K Kalra; Jasjit S Suri Journal: J Cardiovasc Dev Dis Date: 2022-08-15